{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:15:31Z","timestamp":1770707731679,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabonomics methods have gradually become important auxiliary tools for screening disease biomarkers. However, recognition of metabolites or potential biomarkers closely related to either particular clinical symptoms or prognosis has been difficult. The current study aims to identify potential biomarkers of functional dyspepsia (FD) by a new strategy that combined hydrogen nuclear magnetic resonance (<jats:sup>1<\/jats:sup>H NMR)-based metabonomics techniques and an integrative multi-objective optimization (LPIMO) method. First, clinical symptoms of FD were evaluated using the Nepean Dyspepsia Index (NDI) and plasma metabolic profiles were measured by<jats:sup>1<\/jats:sup>H NMR. Correlations between the key metabolites and the NDI scores were calculated. Then, LPIMO was developed to identify a multi-biomarker panel by maximizing diagnostic ability and correlation with the NDI score. Finally, a KEGG database search elicited the metabolic pathways in which the potential biomarkers are involved. The results showed that glutamine, alanine, proline, HDL, \u03b2-glucose, \u03b1-glucose and LDL\/VLDL levels were significantly altered in FD patients. Among them, phosphatidycholine (PtdCho) and leucine\/isoleucine (Leu\/Ile) were positively and negatively correlated with the NDI Symptom Index (NDSI) respectively. Our procedure not only significantly improved the credibility of the biomarkers, but also demonstrated the potential of further explorations and applications to diagnosis and treatment of complex disease.<\/jats:p>","DOI":"10.1038\/srep18852","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T11:25:52Z","timestamp":1452252352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Revealing Potential Biomarkers of Functional Dyspepsia by Combining 1H NMR Metabonomics Techniques and an Integrative Multi-objective Optimization Method"],"prefix":"10.1038","volume":"6","author":[{"given":"Qiaofeng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanrong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuguang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"key":"BFsrep18852_CR1","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack, J. et al. Functional gastroduodenal disorders. Gastroenterology 130(5), 1466\u20131479 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep18852_CR2","first-page":"20","volume":"21","author":"XA Fu Chaowei","year":"2007","unstructured":"Fu Chaowei, X. A. & Weiqing, C. Survey on anxiety and depression in patients with digestive disorders in 10 major cities of China. Continuing Medical Education 21(16), 20\u201322 (2007).","journal-title":"Continuing Medical Education"},{"key":"BFsrep18852_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-230X-8-43","volume":"8","author":"W AnJiang","year":"2008","unstructured":"AnJiang, W. et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC gastroenterology. 8(1), 43 (2008).","journal-title":"BMC gastroenterology."},{"key":"BFsrep18852_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000121346","volume":"26","author":"K Mimidis","year":"2007","unstructured":"Mimidis, K. & Tack, J. Pathogenesis of dyspepsia. Digestive diseases (Basel, Switzerland). 26(3), 194\u2013202 (2007).","journal-title":"Digestive diseases"},{"key":"BFsrep18852_CR5","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2005.09.020","volume":"129","author":"NJ Talley","year":"2005","unstructured":"Talley, N. J., Vakil, N. B. & Moayyedi, P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 129(5), 1756\u20131780 (2005).","journal-title":"Gastroenterology."},{"key":"BFsrep18852_CR6","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3748\/wjg.v18.i18.2231","volume":"18","author":"YS Kim","year":"2012","unstructured":"Kim, Y. S. et al. Plasma levels of acylated ghrelin in patients with functional dyspepsia. World J Gastroenterol. 18(18), 2231\u20132237 (2012).","journal-title":"World J Gastroenterol."},{"key":"BFsrep18852_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MEG.0000000000000001","volume":"26","author":"OS van Boxel","year":"2014","unstructured":"van Boxel, O. S. et al. Functional dyspepsia patients have lower mucosal cholecystokinin concentrations in response to duodenal lipid. Eur J Gastroenterol Hepatol. 26(2), 205\u2013212 (2014).","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"BFsrep18852_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4291\/wjgp.v4.i2.28","volume":"4","author":"AB Witte","year":"2013","unstructured":"Witte, A. B. et al. Duodenal epithelial transport in functional dyspepsia: Role of serotonin. World J Gastrointest Pathophysiol. 4(2), 28\u201336 (2013).","journal-title":"World J Gastrointest Pathophysiol."},{"key":"BFsrep18852_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.dld.2004.07.001","volume":"36","author":"KB Lankarani","year":"2004","unstructured":"Lankarani, K. B., Moghadami, M., Masoumpoor, M., Geramizadeh, B. & Omrani, G. R. Serum leptin level in patients with functional dyspepsia. Dig Liver Dis. 36(11), 717\u2013721 (2004).","journal-title":"Dig Liver Dis."},{"key":"BFsrep18852_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2982.2005.00730.x","volume":"18","author":"MP Jones","year":"2006","unstructured":"Jones, M. P., Dilley, J. B., Drossman, D. & Crowell, M. D. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 18(2), 91\u2013103 (2006).","journal-title":"Neurogastroenterol Motil."},{"key":"BFsrep18852_CR11","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1161\/CIRCULATIONAHA.105.569137","volume":"112","author":"MS Sabatine","year":"2005","unstructured":"Sabatine, M. S. et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 112(25), 3868\u20133875 (2005).","journal-title":"Circulation."},{"key":"BFsrep18852_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nbd.2009.02.019","volume":"35","author":"MP Quinones","year":"2009","unstructured":"Quinones, M. P. & Kaddurah-Daouk, R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiology of disease. 35(2), 165\u2013176 (2009).","journal-title":"Neurobiology of disease."},{"key":"BFsrep18852_CR13","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/bioinformatics\/btp558","volume":"25","author":"H Nam","year":"2009","unstructured":"Nam, H., Chung, B. C., Kim, Y., Lee, K. & Lee, D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 25(23), 3151\u20133157 (2009).","journal-title":"Bioinformatics."},{"key":"BFsrep18852_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jpba.2009.09.042","volume":"51","author":"Q Wu","year":"2010","unstructured":"Wu, Q. et al. 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. J Pharm Biomed Anal. 51(3), 698\u2013704 (2010).","journal-title":"J Pharm Biomed Anal."},{"key":"BFsrep18852_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/jmra.1995.1176","volume":"115","author":"D Wu","year":"1995","unstructured":"Wu, D., Chen, A. & Johnson, C. S. An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses. Journal of magnetic resonance, Series A. 115(2), 260\u2013264 (1995).","journal-title":"Journal of magnetic resonance, Series A."},{"key":"BFsrep18852_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1039\/b302360p","volume":"128","author":"BM Beckwith-Hall","year":"2003","unstructured":"Beckwith-Hall, B. M., Thompson, N. A., Nicholson, J. K., Lindon, J. C. & Holmes, E. A metabonomic investigation of hepatotoxicity using diffusion-edited 1 H NMR spectroscopy of blood serum. Analyst. 128(7), 814\u2013818 (2003).","journal-title":"Analyst."},{"key":"BFsrep18852_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/(SICI)1099-1492(199806\/08)11:4\/5<235::AID-NBM507>3.0.CO;2-V","volume":"11","author":"E Holmes","year":"1998","unstructured":"Holmes, E. et al. Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11, 235\u2013244 (1998).","journal-title":"NMR Biomed."},{"key":"BFsrep18852_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1021\/tx010067f","volume":"14","author":"NJ Waters","year":"2001","unstructured":"Waters, N. J. et al. NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine and plasma in the rat: an integrative metabonomic approach. Chem Res Toxicol. 14(10), 1401\u20131412 (2001).","journal-title":"Chem Res Toxicol."},{"key":"BFsrep18852_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1039\/b205128c","volume":"127","author":"BM Beckwith-Hall","year":"2002","unstructured":"Beckwith-Hall, B. M. et al. Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution 1H NMR spectra of biofluids. Analyst. 127(10), 1283\u20131288 (2002).","journal-title":"Analyst."},{"key":"BFsrep18852_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-5793(02)03476-2","volume":"530","author":"CL Gavaghan","year":"2002","unstructured":"Gavaghan, C. L., Wilson, I. D. & Nicholson, J. K. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett. 530(1-3), 191\u2013196 (2002).","journal-title":"FEBS Lett."},{"key":"BFsrep18852_CR21","doi-asserted-by":"crossref","unstructured":"Chang, D., Weljie, A. & Newton, J. Leveraging latent information in NMR spectra for robust predictive models. Pac Symp Biocomput. 115\u2013126 (2007).","DOI":"10.1142\/9789812772435_0012"},{"key":"BFsrep18852_CR22","doi-asserted-by":"publisher","first-page":"W423","DOI":"10.1093\/nar\/gkn282","volume":"36","author":"S Okuda","year":"2008","unstructured":"Okuda, S. et al. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res. 36(Web Server issue), W423\u2013426 (2008).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep18852_CR23","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3748\/wjg.14.2124","volume":"14","author":"R Mostafa","year":"2008","unstructured":"Mostafa, R. Rome III The functional gastrointestinal disorders, third edition, 2006. World Journal of Gastroenterology. 14(13), 2124\u20132125 (2008).","journal-title":"World Journal of Gastroenterology."},{"key":"BFsrep18852_CR24","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1021\/pr060265y","volume":"5","author":"C Stella","year":"2006","unstructured":"Stella, C. et al. Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 5(10), 2780\u20132788 (2006).","journal-title":"J Proteome Res."},{"key":"BFsrep18852_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jpba.2004.08.002","volume":"36","author":"EM Lenz","year":"2004","unstructured":"Lenz, E. M. et al. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal. 36(4), 841\u2013849 (2004).","journal-title":"J Pharm Biomed Anal."},{"key":"BFsrep18852_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/nbm.935","volume":"18","author":"ME Bollard","year":"2005","unstructured":"Bollard, M. E., Stanley, E. G., Lindon, J. C., Nicholson, J. K. & Holmes, E. NMR-based metabonomic approaches for evaluating ph(ysiological) influences on biofluid composition. NMR Biomed. 18(3), 143\u2013162 (2005).","journal-title":"NMR Biomed."},{"key":"BFsrep18852_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0731-7085(03)00410-2","volume":"33","author":"EM Lenz","year":"2003","unstructured":"Lenz, E. M., Bright, J., Wilson, I. D., Morgan, S. R. & Nash, A. F. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal. 33(5), 1103\u20131115 (2003).","journal-title":"J Pharm Biomed Anal."},{"key":"BFsrep18852_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/gb-2003-4-4-210","volume":"4","author":"X Cui","year":"2003","unstructured":"Cui, X. & Churchill, G. A. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol. 4(4), 210 (2003).","journal-title":"Genome Biol."},{"key":"BFsrep18852_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2014.09.024","volume":"237","author":"NJ Rankin","year":"2014","unstructured":"Rankin, N. J. et al. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis. 237(1), 287\u2013300 (2014).","journal-title":"Atherosclerosis."},{"key":"BFsrep18852_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trac.2007.12.001","volume":"27","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. Quantitative metabolomics using NMR. TrAC Trends in Analytical Chemistry. 27(3), 228\u2013237 (2008).","journal-title":"TrAC Trends in Analytical Chemistry."},{"key":"BFsrep18852_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","volume":"1277","author":"AH Emwas","year":"2015","unstructured":"Emwas, A. H. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol Biol. 1277, 161\u2013193 (2015).","journal-title":"Methods Mol Biol."},{"key":"BFsrep18852_CR32","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1021\/pr3000317","volume":"11","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 11(5), 2937\u20132946 (2012).","journal-title":"J Proteome Res."},{"key":"BFsrep18852_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2049-3002-2-6","volume":"2","author":"KA Liu","year":"2014","unstructured":"Liu, K. A., Lashinger, L. M., Rasmussen, A. J. & Hursting, S. D. Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice. Cancer Metab. 2(1), 6 (2014).","journal-title":"Cancer Metab."},{"key":"BFsrep18852_CR34","doi-asserted-by":"publisher","first-page":"e0127299","DOI":"10.1371\/journal.pone.0127299","volume":"10","author":"MR Nezami Ranjbar","year":"2015","unstructured":"Nezami Ranjbar, M. R. et al. GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort. PLoS One. 10(6), e0127299 (2015).","journal-title":"PLoS One."},{"key":"BFsrep18852_CR35","doi-asserted-by":"publisher","first-page":"544s","DOI":"10.1093\/jn\/136.2.544S","volume":"136","author":"E Blomstrand","year":"2006","unstructured":"Blomstrand, E. A role for branched-chain amino acids in reducing central fatigue. J Nutr. 136(2), 544s\u2013547s (2006).","journal-title":"J Nutr."},{"key":"BFsrep18852_CR36","doi-asserted-by":"publisher","first-page":"E392","DOI":"10.1152\/ajpendo.00582.2007","volume":"294","author":"HC Dreyer","year":"2008","unstructured":"Dreyer, H. C. et al. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab. 294(2), E392\u2013400 (2008).","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"8","key":"BFsrep18852_CR37","first-page":"E736","volume":"309","author":"MM Boulet","year":"2015","unstructured":"Boulet, M. M. et al. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. 309(8), E736\u2013746(2015).","journal-title":"Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk."},{"key":"BFsrep18852_CR38","doi-asserted-by":"publisher","first-page":"25382","DOI":"10.1074\/jbc.M110.139477","volume":"285","author":"H Marcucci","year":"2010","unstructured":"Marcucci, H., Paoletti, L., Jackowski, S. & Banchio, C. Phosphatidylcholine biosynthesis during neuronal differentiation and its role in cell fate determination. J Biol Chem. 285(33), 25382\u20132593 (2010).","journal-title":"J Biol Chem."},{"key":"BFsrep18852_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbalip.2012.09.009","volume":"1831","author":"P Fagone","year":"2013","unstructured":"Fagone, P. & Jackowski, S. Phosphatidylcholine and the CDP-choline cycle. Biochim Biophys Acta. 1831(3), 523\u2013532 (2013).","journal-title":"Biochim Biophys Acta."},{"key":"BFsrep18852_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000354707","volume":"31","author":"W Stremmel","year":"2013","unstructured":"Stremmel, W. & Gauss, A. Lecithin as a therapeutic agent in ulcerative colitis. Dig Dis. 31(3\u20134), 388\u2013390 (2013).","journal-title":"Dig Dis."},{"key":"BFsrep18852_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000320407","volume":"28","author":"W Stremmel","year":"2010","unstructured":"Stremmel, W., Hanemann, A., Ehehalt, R., Karner, M. & Braun, A. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis? Dig Dis. 28(3), 490\u2013496 (2010).","journal-title":"Dig Dis."},{"key":"BFsrep18852_CR42","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/ajg.2014.104","volume":"109","author":"M Karner","year":"2014","unstructured":"Karner, M. et al. First multicenter study of modified release phosphatidylcholine \u201cLT-02\u201d in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses. Am J Gastroenterol 109(7), 1041\u20131051 (2014).","journal-title":"Am J Gastroenterol"},{"key":"BFsrep18852_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1432-1033.1996.00073.x","volume":"235","author":"SW Hermans","year":"1996","unstructured":"Hermans, S. W. et al. Diradylglycerol formation in cholecystokinin-stimulated rabbit pancreatic acini. Assessment of precursor phospholipids by means of molecular species analysis. Eur J Biochem 235(1\u20132), 73\u201381 (1996).","journal-title":"Eur J Biochem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep18852.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18852","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18852.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T02:39:36Z","timestamp":1748745576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep18852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,10]]}},"alternative-id":["BFsrep18852"],"URL":"https:\/\/doi.org\/10.1038\/srep18852","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]},"assertion":[{"value":"29 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18852"}}